Cargando…
Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress
Despite the increasing number of manuscripts describing potential alternative antileishmanial compounds, little is advancing on translating these knowledges to new products to treat leishmaniasis. This is in part due to the lack of standardisations during pre-clinical drug discovery stage and also d...
Autores principales: | do Monte, Rubens Lima, Moreira, Paulo Otávio Lourenço, de Sousa, Alessandra Mara, Garcia, Miguel Antonio do Nascimento, Maran, Suellen Rodrigues, Moretti, Nilmar Silvio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944189/ https://www.ncbi.nlm.nih.gov/pubmed/35320824 http://dx.doi.org/10.1590/0074-02760220403 |
Ejemplares similares
-
Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
por: Martinez-Hernandez, J. Eduardo, et al.
Publicado: (2021) -
Target-directed catalytic metallodrugs
por: Joyner, J.C., et al.
Publicado: (2013) -
Exploring direct and indirect targets of current antileishmanial drugs using a novel thermal proteomics profiling approach
por: Ibarra-Meneses, Ana Victoria, et al.
Publicado: (2022) -
Towards Elucidating the Rotary Mechanism of the Archaellum Machinery
por: Nuno de Sousa Machado, João, et al.
Publicado: (2022) -
Ruthenacarborane–Phenanthroline Derivatives as Potential Metallodrugs
por: Kellert, Martin, et al.
Publicado: (2020)